Assessing testicular function and semen quality in young male cancer survivors
Official title: Effect of Cancer Treatment on Testicular Function and Semen Quality in Male Childhood and Adolescent Cancer Survivors
Run by The University of Hong Kong · NCT06587477 · Data updated 2026-11-12
This study is trying to see how well the testicles are working and the quality of semen in young men who survived cancer as kids or teens, compared to men their age who didn't have cancer.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | Men only |
| Enrollment | 200 (estimated) |
| Sponsor | The University of Hong Kong Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | January 16, 2023 |
| Main results expected | December 31, 2027 |
| Study ends | June 30, 2028 |
| Registry record updated | September 19, 2024 |
| Trial ID | NCT06587477 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are men aged 18 to 50 who received cancer treatment before age 18 and have been in remission for at least two years.
✕Probably not a fit
Patients who are unable to provide semen samples or have specific medical conditions such as testicular cancer or are on testosterone replacement therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the testicular function and semen quality in male survivors of childhood and adolescent cancer who are now adults. Participants will include men aged 18 to 50 who received chemotherapy or radiotherapy for cancer diagnosed before age 18 and have been in remission for at least two years. The study will compare their testicular function with that of age-matched controls from a premarital check-up clinic. Data will be collected through hormonal profiling, semen analysis, and questionnaires.
Why it matters
Potential benefit: If successful, this study could provide critical insights for improving pre-treatment counseling and post-treatment care for young male cancer survivors.
How similar studies have gone: Other studies have shown success in assessing long-term effects of cancer treatment on reproductive health, making this approach both relevant and necessary.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men who have received chemotherapy and/ or radiotherapy for cancer diagnosed when they were \< 18 years old. * \> 18 years old to 50 years old * Cancer in remission for at least 2 years Exclusion Criteria: * Unable to ejaculate by masturbation to provide semen samples * Cryptorchidism, testicular cancer, history of vasectomy * On testosterone replacement therapy * Refusal to join the study
Where it's running
-
Queen Mary Hospital
Hong Kong, China Recruiting
Study contacts
- Study coordinator: Jennifer Ko
- Email: jenko@hku.hk
- Phone: 22554647
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Emotional stress and immunotherapy outcomes in liver cancer
This study will see if emotional distress changes how well immunotherapy works for people with hepatocellular carcinoma.
-
Microfluidic versus density-gradient sperm preparation for ICSI with PGT-A using sibling oocytes
This trial will test whether microfluidic sperm preparation leads to higher fertilization, blastulation, and euploid embryo rates than standard density-gradient centrifugation for people having ICSI with PGT-A.
-
Exploring how sleep disturbances affect lung cancer treatment outcomes
This study is trying to see how sleep problems affect the success of immune treatments in people with lung cancer.
-
Monitoring postoperative complications in cancer patients with a smart system
This study is testing a smart monitoring system that sends alerts about vital signs to see if it helps high-risk cancer patients recover better after surgery compared to regular monitoring.
-
Evaluating Redsenol-1 Plus for cancer-related fatigue in adults
This study is testing if a new treatment called Redsenol-1 Plus can help adults with cancer-related fatigue feel better compared to a placebo.
-
Using radiofrequency to reduce liver cancer recurrence after surgery
This study is testing if using radiofrequency during liver surgery can help prevent liver cancer from coming back and improve survival for patients with questionable surgical margins.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.